$13.40
-0.81-5.70%
Pre-Market: 6:56 AM EDT
Comments
Loading...
NeoGenomics (NASDAQ:NEO) Stock Quotes, Forecast and News Summary
NeoGenomics Stock (NASDAQ: NEO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy NeoGenomics (NEO) stock?
You can purchase shares of NeoGenomics (NASDAQ:NEO) through any online brokerage.
Who are NeoGenomics (NEO) competitors?
Other companies in NeoGenomics’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), GeneDx Hldgs (NASDAQ:WGS), Hims & Hers Health (NYSE:HIMS) and Privia Health Gr (NASDAQ:PRVA).
What is the forecast, or price target, for NeoGenomics (NEO) stock?
NeoGenomics has a consensus price target of $19.62.
What is the current price for NeoGenomics (NEO)?
The stock price for NeoGenomics (NASDAQ: NEO) is $13.4 last updated January 21, 2025 at 6:56 AM EST.
Does NeoGenomics (NEO) pay a dividend?
There are no upcoming dividends for NeoGenomics.
When is NeoGenomics (NASDAQ:NEO) reporting earnings?
NeoGenomics’s Q4 earnings are confirmed for Tuesday, February 18, 2025.
Is NeoGenomics (NEO) going to split?
There is no upcoming split for NeoGenomics.
What sector and industry does NeoGenomics (NEO) operate in?
NeoGenomics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.